Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015 Market Size, Trends, Growth
This report provides comprehensive information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease) and special features on late-stage and discontinued projects. Complete Report is Available At: http://www.researchbeam.com/coronary-artery-disease-cad-ischemic-heart-disease-pipeline-review-h1-2015-market
This report provides comprehensive information on the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Coronary Artery Disease (CAD) (Ischemic Heart Disease) and special features on late-stage and discontinued projects.
Complete Report is Available At:
http://www.researchbeam.com/coronary-artery-disease-cad-ischemic-heart-disease-pipeline-review-h1-2015-market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong><br />
(<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong><br />
<strong>Disease</strong>) - <strong>Pipeline</strong> <strong>Review</strong>,<br />
<strong>H1</strong> <strong>2015</strong><br />
TELEPHONE: +1 (855) 711-1555<br />
E-MAIL: help@researchbeam.com
Report Overview<br />
Summary<br />
Global <strong>Market</strong>s Direct’s, ‘<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong><br />
<strong>2015</strong>’, provides an overview of the <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>)’s<br />
therapeutic pipeline.<br />
This report provides comprehensive information on the therapeutic development for <strong>Coronary</strong> <strong>Artery</strong><br />
<strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>), complete with comparative analysis at various stages,<br />
therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA)<br />
and molecule type, along with latest updates, and featured news and press releases. It also reviews<br />
key players involved in the therapeutic development for <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong><br />
<strong>Heart</strong> <strong>Disease</strong>) and special features on late-stage and discontinued projects.<br />
Global <strong>Market</strong>s Direct’s report features investigational drugs from across globe covering over 20<br />
therapy areas and nearly 3,000 indications. The report is built using data and information sourced<br />
from Global <strong>Market</strong>s Direct’s proprietary databases, Company/University websites, SEC filings, investor<br />
presentations and featured press releases from company/university sites and industry-specific third<br />
party sources, put together by Global <strong>Market</strong>s Direct’s team. Drug profiles/records featured in the<br />
report undergoes periodic updation following a stringent set of processes that ensures that all the<br />
profiles are updated with the latest set of information. Additionally, processes including live news &<br />
deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most<br />
recent developments are captured on a real time basis.
Report Overview<br />
The report enhances decision making capabilities and help to create effective counter strategies to<br />
gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to<br />
produce first-in-class and best-in-class products.<br />
Note*: Certain sections in the report may be removed or altered based on the availability and<br />
relevance of data for the indicated disease.<br />
Scope<br />
- The report provides a snapshot of the global therapeutic landscape of <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>)<br />
(<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>)<br />
- The report reviews key pipeline products under drug profile section which includes, product<br />
description, MoA and R&D brief, licensing and collaboration details & other developmental activities<br />
- The report reviews key players involved in the therapeutics development for <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong><br />
(<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) and enlists all their major and minor projects<br />
- The report summarizes all the dormant and discontinued pipeline projects<br />
- A review of the <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) products under<br />
development by companies and universities/research institutes based on information derived from<br />
company and industry-specific sources<br />
- <strong>Pipeline</strong> products coverage based on various stages of development ranging from pre-registration till<br />
discovery and undisclosed stages
Report Overview<br />
Reasons to buy<br />
‣ - Provides strategically significant competitor information, analysis, and insights to formulate<br />
effective R&D development strategies<br />
‣ - Identify emerging players with potentially strong product portfolio and create effective counterstrategies<br />
to gain competitive advantage<br />
‣ - Develop strategic initiatives by understanding the focus areas of leading companies<br />
‣ - Identify and understand important and diverse types of therapeutics under development for<br />
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>)<br />
‣ - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline<br />
‣ - Devise corrective measures for pipeline projects by understanding <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>)<br />
(<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) pipeline depth and focus of Indication therapeutics<br />
‣ - Develop and design in-licensing and out-licensing strategies by identifying prospective partners<br />
with the most attractive projects to enhance and expand business potential and scope
Table of Contents<br />
Table of Contents<br />
Table of Contents 2<br />
List of Tables 8<br />
List of Figures 9<br />
Introduction 10<br />
Global <strong>Market</strong>s Direct Report Coverage 10<br />
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) Overview 11<br />
Therapeutics Development 12<br />
<strong>Pipeline</strong> Products for <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - Overview 12<br />
<strong>Pipeline</strong> Products for <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - Comparative Analysis<br />
13<br />
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - Therapeutics under Development by<br />
Companies 14<br />
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - Therapeutics under Investigation by<br />
Universities/Institutes 17<br />
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - <strong>Pipeline</strong> Products Glance 18<br />
Enquire About Report:<br />
http://www.researchbeam.com/coronary-artery-disease-cad-ischemic-heart-disease-pipelinereview-h1-<strong>2015</strong>-market/enquire-about-report
FOR MORE DETAILS<br />
Visit us at :<br />
www.researchbeam.com/coronary-artery-disease-cad-ischemic-heart-diseasepipeline-review-h1-<strong>2015</strong>-market<br />
Stay With Us:<br />
TELEPHONE: +1 (855) 711-1555<br />
E-MAIL: sales@researchbeam.com<br />
5933 NE Win Sivers Drive,<br />
#205, Portland, OR 97220<br />
United States
Change language